Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
Journal of Neural Transmission1996Vol. 103(8-9), pp. 987–1041
Citations Over TimeTop 1% of 1996 papers
Related Papers
- → Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice(1996)97 cited
- → Acute and Chronic 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Administrations Elicit Similar Microglial Activation in the Substantia Nigra of Monkeys(2009)45 cited
- → Protective effect of Actinidia arguta in MPTP-induced Parkinson’s disease model mice(2021)14 cited
- → GM1 Administration Prevents Alterations in BCL‐2 and Bax Expression in Substantia Nigra Neurons Following MPTP Administrationa(1998)
- → Inhibition of Cdk5/p25 by TFP5 protects dopaminergic neurons in MPTP-induced mouse model of Parkinson's disease(2015)